Liberty One Investment Management, LLC Crispr Therapeutics Ag Transaction History

Liberty One Investment Management, LLC

$969 Million
Q3 2024

A detailed history of Liberty One Investment Management, LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Liberty One Investment Management, LLC holds 2,557 shares of CRSP stock, worth $104,683. This represents 0.01% of its overall portfolio holdings.

Number of Shares

2,557

Previous 2,705 5.47%

Holding current value

$104,683

Previous $146,000 17.81%

% of portfolio

0.01%

Previous 0.02%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	SELL	$44.62 - $62.75 $6,603 - $9,287	-148 Reduced 5.47%	2,557 $120,000
Q2 2024 Jul 22, 2024	BUY	$51.17 - $68.18 $17,193 - $22,908	336 Added 14.18%	2,705 $146,000
Q1 2024 Apr 30, 2024	SELL	$60.67 - $89.12 $63,521 - $93,308	-1,047 Reduced 30.65%	2,369 $161,000
Q4 2023 Jan 26, 2024	BUY	$38.62 - $72.18 $1,544 - $2,887	40 Added 1.18%	3,416 $213,000
Q3 2023 Nov 03, 2023	SELL	$45.39 - $59.0 $12,346 - $16,048	-272 Reduced 7.46%	3,376 $153,000
Q2 2023 Aug 04, 2023	SELL	$43.47 - $67.77 $9,824 - $15,316	-226 Reduced 5.83%	3,648 $204,000
Q1 2023 May 15, 2023	SELL	$41.0 - $56.12 $1,558 - $2,132	-38 Reduced 0.97%	3,874 $175,000
Q3 2022 Nov 16, 2022	BUY	$61.1 - $83.78 $136,680 - $187,415	2,237 Added 133.55%	3,912 $256,000
Q2 2022 Aug 01, 2022	SELL	$43.23 - $73.83 $101,417 - $173,205	-2,346 Reduced 58.34%	1,675 $271,000
Q1 2022 May 03, 2022	BUY	$53.19 - $79.24 $74,838 - $111,490	1,407 Added 53.83%	4,021 $252,000
Q4 2021 Jan 21, 2022	BUY	$70.09 - $111.29 $70,790 - $112,402	1,010 Added 62.97%	2,614 $198,000
Q3 2021 Oct 20, 2021	SELL	$110.2 - $156.64 $7,824 - $11,121	-71 Reduced 4.24%	1,604 $180,000
Q2 2021 Jul 20, 2021	BUY	$100.84 - $161.89 $38,117 - $61,194	378 Added 29.14%	1,675 $271,000
Q1 2021 Apr 06, 2021	BUY	$110.72 - $210.04 $37,534 - $71,203	339 Added 35.39%	1,297 $158,000
Q4 2020 Jan 20, 2021	SELL	$79.67 - $173.23 $1,115 - $2,425	-14 Reduced 1.44%	958 $147,000
Q3 2020 Nov 03, 2020	BUY	$78.5 - $100.64 $28,103 - $36,029	358 Added 58.31%	972 $81,000
Q2 2020 Jul 22, 2020	BUY	$38.5 - $76.05 $23,639 - $46,694	614 New	614 $45,000

Others Institutions Holding CRSP

# of Institutions

490

Shares Held

58M

Call Options Held

1.1M

Put Options Held

1.9M

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.19B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Liberty One Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Liberty One Investment Management, LLC with notifications on news.

Account

Liberty One Investment Management, LLC Crispr Therapeutics Ag Transaction History